Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future

Cancer Treatment Reviews

Volumn 41, Issue 9, 2015, Pages 742-753

  Datta, N R ^a   Ordóñez, S Gómez ^a   Gaipl, U S ^b   Paulides, M M ^c   Crezee, H ^d   Gellermann, J ^e   Marder, D ^a   Puric, E ^a   Bodis, S ^a,f  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c ERASMUS MC CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Praxis Zentrum für Strahlentherapie und Radioonkologie   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chemotherapy; Clinical trials; Hyperthermia; Radiotherapy; Thermal dose; Treatment planning

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; GERM CELL TUMOR; GLIOBLASTOMA; HUMAN; HYPERTHERMIC THERAPY; IMMUNOMODULATION; NASOPHARYNX CANCER; NON MUSCLE INVASIVE BLADDER CANCER; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCREAS CANCER; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTON THERAPY; RETREATMENT; REVIEW; SOFT TISSUE SARCOMA; SOLID TUMOR; STOMACH CANCER; THERMOMETRY; THERMORADIOCHEMOTHERAPY; THERMORADIOTHERAPY; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR REGRESSION; UTERINE CERVIX CANCER; UVEA MELANOMA; CLINICAL TRIAL (TOPIC); MULTIMODALITY CANCER THERAPY; NEOPLASMS; PROCEDURES;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS;

EID: 84945460646     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2015.05.009     Document Type: Review

References (121)

1. Breasted JH. The Edwin Schmid surgical papyrus. In: Licht S, editor. Therapeutic heat and coal. 2nd ed., Baltimore: Waverly Press; 1930: p. 196.
2. Singh B.B. Hyperthermia: an ancient science in India. Int J Hyperthermia 1991, 7:1-6.
3. Coley W.B. The treatment of malignant tumors by repeated inoculations of erysipelas, with a report of ten original cases. Am J Med Sci 1893, 105:488-511.
4. Muller C. Eine neue Behandlungsmethode bosartiger. Geschwulste 1910, 57:1490-1493.
5. Warren S.L. Preliminary study of the effects of artificial fever upon hopeless tumor cases. Am J Roentgenol 1935, 33:75-87.
6. van der Zee J., Vujaskovic Z., Kindo M., Sugahara T. The Kadota Fund International Forum 2004 - clinical group consensus. Int J Hyperthermia 2008, 24:111-112.
7. Hurwitz M., Stauffer P. Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care. Semin Oncol 2014, 41:714-729.
8. Horsman M.R., Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007, 19:418-426.
9. Dewey W.C. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994, 10:457-483.
10. Perez C.A., Pajak T., Emami B., Hornback N.B., Tupchong L., Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol 1991, 14:133-141.
11. Perez C.A., Gillespie B., Pajak T., Hornback N.B., Emami B., Rubin P. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989, 16:551-558.
12. Emami B., Scott C., Perez C.A., Asbell S., Swift P., Grigsby P., et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1996, 34:1097-1104.
13. Diagnostic and therapeutic technology assessment. Hyperthermia as adjuvant treatment for recurrent breast cancer and primary malignant glioma. JAMA 1994, 271:797-802.
14. Datta N.R., Puric E., Schneider R., Weber D.C., Rogers S., Bodis S. Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale. Int J Hyperthermia 2014, 30:524-530.
15. Issels R. Hyperthermia combined with chemotherapy - biological rationale, clinical application, and treatment results. Onkologie 1999, 22:374-381.
16. Dewhirst M.W., Vujaskovic Z., Jones E., Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005, 21:779-790.
17. Baronzio G., Gramaglia A., Fiorentini G. Hyperthermia and immunity. A brief overview. In Vivo 2006, 20:689-695.
18. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 2003;79:672-80.
19. Repasky E.A., Evans S.S., Dewhirst M.W. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res 2013, 1:210-216.
20. Skitzki J.J., Repasky E.A., Evans S.S. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs 2009, 10:550-558.
21. Demaria S., Ng B., Devitt M.L., Babb J.S., Kawashima N., Liebes L., et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004, 58:862-870.
22. Frey B., Rubner Y., Wunderlich R., Weiss E.M., Pockley A.G., Fietkau R., et al. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies. Curr Med Chem 2012, 19:1751-1764.
23. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-1059.
24. Chen T., Guo J., Han C., Yang M., Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via tlr4 pathway. J Immunol 2009, 182:1449-1459.
25. Todryk S., Melcher A.A., Hardwick N., Linardakis E., Bateman A., Colombo M.P., et al. Heat shock protein 70 induced during tumor cell killing induces th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 1999, 163:1398-1408.
26. Multhoff G., Pockley A.G., Streffer C., Gaipl U.S. Dual role of heat shock proteins (HSPs) in anti-tumor immunity. Curr Mol Med 2012, 12:1174-1182.
27. Basu S., Binder R.J., Suto R., Anderson K.M., Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000, 12:1539-1546.
28. Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P.J., Kuppner M.C., et al. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 2002, 169:5424-5432.
29. Schildkopf P., Frey B., Mantel F., Ott O.J., Weiss E.M., Sieber R., et al. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 2010, 391:1014-1020.
30. Schildkopf P., Frey B., Ott O.J., Rubner Y., Multhoff G., Sauer R., et al. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 2011, 101:109-115.
31. Mantel F., Frey B., Haslinger S., Schildkopf P., Sieber R., Ott O.J., et al. Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol 2010, 186:587-599.
32. Frey B., Weiss E.M., Rubner Y., Wunderlich R., Ott O.J., Sauer R., et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012, 28:528-542.
33. Knippertz I., Stein M.F., Dorrie J., Schaft N., Muller I., Deinzer A., et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia 2011, 27:591-603.
34. Datta NR, Grobholz R, Puric E, Bode-Lesniewska B, Lomax N, Khan S, et al. Enhanced tumour regression in a patient of liposarcoma treated with radiotherapy and hyperthermia: hint for dynamic immunomodulation by hyperthermia. Int J Hyperthermia 2015 Apr 20:1-4. [Epub ahead of print].
35. Toraya-Brown S., Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014, 30:531-539.
36. Schildkopf P., Ott O.J., Frey B., Wadepohl M., Sauer R., Fietkau R., et al. Biological rationales and clinical applications of temperature controlled hyperthermia-implications for multimodal cancer treatments. Curr Med Chem 2010, 17:3045-3057.
37. Vernon C.C., Hand J.W., Field S.B., Machin D., Whaley J.B., van der Zee J., et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International collaborative hyperthermia group. Int J Radiat Oncol Biol Phys 1996, 35:731-744.
38. Masunaga S., Hiraoka M., Takahashi M., Jo S., Akuta K., Nishimura Y., et al. Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer-comparison of results with radiotherapy alone. Int J Hyperthermia 1990, 6:487-497.
39. Zolciak-Siwinska A., Piotrkowicz N., Jonska-Gmyrek J., Nicke-Psikuta M., Michalski W., Kawczyńska M., et al. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy - a phase III study. Radiother Oncol 2013, 109:194-199.
40. Franckena M., Stalpers L.J., Koper P.C., Wiggenraad R.G., Hoogenraad W.J., van Dijk J.D., et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch deep hyperthermia trial. Int J Radiat Oncol Biol Phys 2008, 70:1176-1182.
41. Harima Y., Nagata K., Harima K., Ostapenko V.V., Tanaka Y., Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001, 17:97-105.
42. Sharma S., Singhal S., Sandhu A.P., Ghoshal S., Gupta B.D., Yadav N.S. Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastasis. Asia Oceania J Obstet Gynaecol 1991, 17:5-12.
43. Datta N.R., Bose A.K., Kapoor H.K. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Indian Med Gazette 1987, 121:68-71.
44. Chen H.W., Fan J.J., Luo W. A randomized trial of hyperthermia-radiochemotherapy for uterine cervix cancer. Zhonghua Zhong Liu Za Zhi 1997, 24:249-251.
45. Wen Q.L., He L.J., Ren P.R., Chen C.Q., Wu J.B. Comparing radiotherapy with or without intracavitary hyperthermia in the treatment of primary nasopharyngeal carcinoma: a retrospective analysis. Tumori 2014, 100:49-54.
46. Kang M., Liu W.Q., Qin Y.T., Wei Z.X., Wang R.S. Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastases. Asian Pac J Cancer Prev 2013, 14:7395-7400.
47. Hua Y., Ma S., Fu Z., Hu Q., Wang L., Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study. Int J Hyperthermia 2011, 27:180-186.
48. Huilgol N.G., Gupta S., Sridhar C.R. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther 2010, 6:492-496.
49. Hiraki Y., Nakajo M., Miyaji N., Takeshita T., Churei H., Ogita M. Effectiveness of RF capacitive hyperthermia combined with radiotherapy for stages III and IV oro-hypopharyngeal cancers: a non-randomized comparison between thermoradiotherapy and radiotherapy. Int J Hyperthermia 1998, 14:445-457.
50. Valdagni R., Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994, 28:163-169.
51. Svetitsky P.V. Effect of microwave and ionizing radiation in patients with recurrent laryngeal carcinoma. J Laryngol Otol 1990, 104:704-705.
52. Datta N.R., Bose A.K., Kapoor H.K., Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990, 6:479-486.
53. van der Zee J., González González D., van Rhoon G.C., van Dijk J.D., van Putten W.L., Hart A.A. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000, 355:1119-1125.
54. Trotter J.M., Edis A.J., Blackwell J.B., Lamb M.H., Bayliss E.J., Shepherd J.M., et al. Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australas Radiol 1996, 40:298-305.
55. You Y.T., Wang J.Y., Changchien C.R., Chen J.S., Hsu K.C., Tang R., et al. An alternative treatment of anal squamous cell carcinoma: combined radiotherapy and chemotherapy. J Surg Oncol 1993, 52:42-45.
56. Berdov B.A., Menteshashvili G.Z. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990, 6:881-890.
57. Masunaga S.I., Hiraoka M., Akuta K., Nishimura Y., Nagata Y., Jo S., et al. Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer. Int J Hyperthermia 1994, 10:31-40.
58. Matsui K., Takebayashi S., Watai K., Kakehi M., Kubota Y., Yao M., et al. Combination radiotherapy of urinary bladder carcinoma with chemohyperthermia. Int J Hyperthermia 1991, 7:19-26.
59. Nozoe T., Kuwano H., Watanabe M., Yasuda M., Sadanaga N., Mimori K., et al. The long-term results of pre-operative hyperthermo-chemo-radiotherapy for oesophageal carcinoma - a comparison with preoperative radiation therapy alone. Eur J Surg Oncol 1995, 21:374-378.
60. Kuwano H., Sumiyoshi K., Watanabe M., Sadanaga N., Nozoe T., Yasuda M., et al. Preoperative hyperthermia combined with chemotherapy and irradiation for the treatment of patients with esophageal carcinoma. Tumori 1995, 81:18-22.
61. Mitsumori M., Zeng Z.F., Oliynychenko P., Park J.H., Choi I.B., Tatsuzaki H., et al. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Clin Oncol 2007, 12:192-198.
62. Karasawa K., Muta N., Nakagawa K., Hasezawa K., Terahara A., Onogi Y., et al. Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1994, 30:1171-1177.
63. Jones E.L., Oleson J.R., Prosnitz L.R., Samulski T.V., Vujaskovic Z., Yu D., et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005, 23:3079-3085.
64. Yarovoy A.A., Magaramov D.A., Bulgakova E.S. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone. Brachytherapy 2012, 11:224-229.
65. Kouloulias V., Plataniotis G., Kouvaris J., Dardoufas C., Gennatas C., Uzunoglu N., et al. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 2005, 28:91-99.
66. Overgaard J., Gonzalez Gonzalez D., Hulshof M.C., Arcangeli G., Dahl O., Mella O., et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996, 12:3-20.
67. Vasanthan A., Mitsumori M., Park J.H., Zhi-Fan Z., Yu-Bin Z., Oliynychenko P., et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2005, 61:145-153.
68. Jones EL, Pronisnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, et al. In regard to Vasanathan et al. Int J Radiat Oncol Biol Phys 2005;63:644.
69. Sneed P.K., Stauffer P.R., McDermott M.W., Diederich C.J., Lamborn K.R., Prados M.D., et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998, 40:287-295.
70. Zhao C., Chen J., Yu B., Chen X. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy. Int J Radiat Biol 2014, 90:853-858.
71. Shchepotin I.B., Evans S.R., Chorny V., Osinsky S., Buras R.R., Maligonov P., et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol 1994, 3:37-44.
72. Maluta S., Schaffer M., Pioli F., Dall'oglio S., Pasetto S., Schaffer P.M., et al. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer: an open-label comparative cohort trial. Strahlenther Onkol 2011, 187:619-625.
73. Desjardins L., Lumbroso-Le Rouic L., Levy-Gabriel C., Dendale R., Delacroix S., Nauraye C., et al. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res 2006, 38:255-260.
74. Maluta S., Dall'oglio S., Romano M., Marciai N., Pioli F., Giri M.G., et al. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia 2007, 23:451-456.
75. Hurwitz M.D., Hansen J.L., Prokopios-Davos S., Manola J., Wang Q., Borenstein B.A., et al. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer: long-term results of DFCI 94-153 from Dana-Farber Cancer Institute study 94-153. Cancer 2011, 117:510-516.
76. Colombo R., Salonia A., Leib Z., Pavone-Macaluso M., Engelstein D. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-c alone as adjuvant treatment for non-muscle-invasive bladder cancer (nmibc). BJU Int 2011, 107:912-918.
77. Shen H., Li X.D., Wu C.P., Yin Y.M., Wang R.S., Shu Y.Q. The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. Int J Hyperthermia 2011, 27:27-32.
78. Issels R.D., Lindner L.H., Verweij J., Wust P., Reichardt P., Schem B.C., et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010, 11:561-570.
79. Sugimachi K., Kuwano H., Ide H., Toge T., Saku M., Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 1994, 10:485-493.
80. Wessalowski R., Schneider D.T., Mils O., Friemann V., Kyrillopoulou O., Schaper J., et al. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Lancet Oncol 2013, 14:843-852.
81. Chou C.K. Use of heating rate and specific absorption rate in the hyperthermia clinic. Int J Hyperthermia 1990, 6:367-370.
82. Sapareto S.A., Dewey W.C. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984, 10:787-800.
83. Dewhirst M.W., Viglianti B.L., Lora-Michiels M., Hanson M., Hoopes P.J. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003, 19:267-294.
84. Gellermann J., Wust P., Stalling D., Seebass M., Nadobny J., Beck R., et al. Clinical evaluation and verification of the hyperthermia treatment planning system Hyperplan. Int J Radiat Oncol Biol Phys 2000, 47:1145-1156.
85. Paulides M.M., Stauffer P.R., Neufeld E., Maccarini P.F., Kyriakou A., Canters R.A., et al. Simulation techniques in hyperthermia treatment planning. Int J Hyperthermia 2013, 29:346-357.
86. Fortunati V., Verhaart R.F., van der Lijn F., Niessen W.J., Veenland J.F., Paulides M.M., et al. Tissue segmentation of head and neck ct images for treatment planning: a multiatlas approach combined with intensity modeling. Med Phys 2013, 40:071905.
87. Verhaart R.F., Fortunati V., Verduijn G.M., van Walsum T., Veenland J.F., Paulides M.M. CT-based patient modeling for head and neck hyperthermia treatment planning: manual versus automatic normal-tissue-segmentation. Radiother Oncol 2014, 111:158-163.
88. van Rhoon G.C., Wust P. Introduction: non-invasive thermometry for thermotherapy. Int J Hyperthermia 2005, 21:489-495.
89. Lüdemann L., Wlodarczyk W., Nadobny J., Weihrauch M., Gellermann J., Wust P. Non-invasive magnetic resonance thermography during regional hyperthermia. Int J Hyperthermia 2010, 26:273-282.
90. Gellermann J., Hildebrandt B., Issels R., Ganter H., Wlodarczyk W., Budach V., et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 2006, 107:1373-1382.
91. Gellermann J., Wlodarczyk W., Hildebrandt B., Ganter H., Nicolau A., Rau B., et al. Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 2005, 65:5872-5880.
92. Craciunescu O.I., Stauffer P.R., Soher B.J., Wyatt C.R., Arabe O., Maccarini P., et al. Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. Med Phys 2009, 36:4848-4858.
93. Fani F., Schena E., Saccomandi P., Silvestri S. CT-based thermometry: an overview. Int J Hyperthermia 2014, 30:219-227.
94. Kok H.P., Ciampa S., de Kroon-Oldenhof R., Steggerda-Carvalho E.J., van Stam G., Vording Zum Vorde Sive., et al. Toward online adaptive hyperthermia treatment planning: correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int J Radiat Oncol Biol Phys 2014, 90:438-445.
95. Fatehi D., van der Zee J., Notenboom A., van Rhoon G.C. Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 2007, 183:479-486.
96. Stauffer PR, Craciunescu OI, Maccarini PF, Arunachalam K, Arabe O, Stakhursky V, et al. Clinical utility of magnetic resonance thermal imaging (MRTI) for realtime guidance of deep hyperthermia. In: Ryan TP, editor. Proceedings of SPIE. San Jose: SPIE Press; 2009. p. OI-1-12.
97. Weihrauch M., Wust P., Weiser M., Nadobny J., Eisenhardt S., Budach V., et al. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys 2007, 34:4717-4725.
98. Canters R.A., Franckena M., van der Zee J., van Rhoon G.C. Optimizing deep hyperthermia treatments: are locations of patient pain complaints correlated with modelled SAR peak locations?. Phys Med Biol 2011, 56:439-451.
99. Rijnen Z., Bakker J.F., Canters R.A., Togni P., Verduijn G.M., Levendag P.C., et al. Clinical integration of software tool VEDO for adaptive and quantitative application of phased array hyperthermia in the head and neck. Int J Hyperthermia 2013, 29:181-193.
100. Canters R.A., Franckena M., van der Zee J., van Rhoon G.C. Complaint-adaptive power density optimization as a tool for HTP-guided steering in deep hyperthermia treatment of pelvic tumors. Phys Med Biol 2008, 53:6799-6820.
101. Franckena M., Canters R., Termorshuizen F., Van Der Zee J., van Rhoon G. Clinical implementation of hyperthermia treatment planning guided steering: a cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 2010, 26:145-157.
102. Togni P., Rijnen Z., Numan W.C., Verhaart R.F., Bakker J.F., van Rhoon G.C., et al. Electromagnetic redesign of the hypercollar applicator: toward improved deep local head-and-neck hyperthermia. Phys Med Biol 2013, 58:5997-6009.
103. Fortunati V, Verhaart RF, van der Lijn F, Niessen WJ, Veenland JF, Paulides MM, et al. Hyperthermia critical tissues automatic segmentation of head and neck CT images using atlas registration and graph cuts. IEEE-ISBI. Barcelona 2012, pp. 1683-86, doi: . doi:10.1109/ISBI.2012.6235902.
104. Fortunati V., Verhaart R.F., Angeloni F., van der Lugt A., Niessen W.J., Veenland J.F., et al. Feasibility of multimodal deformable registration for head and neck tumor treatment planning. Int J Radiat Oncol Biol Phys 2014, 90:85-93.
105. Ranneberg M., Weiser M., Weihrauch M., Budach V., Gellermann J., Wust P. Regularized antenna profile adaptation in online hyperthermia treatment. Med Phys 2010, 37:5382-5394.
106. van Lier A.L., Raaijmakers A., Voigt T., Lagendijk J.J., Luijten P.R., Katscher U., et al. Electrical properties tomography in the human brain at 1.5, 3, and 7T: a comparison study. Magn Reson Med 2014, 71:354-363.
107. Balidemaj E., van Lier A.L., Crezee H., Nederveen A.J., Stalpers L.J., van den Berg C.A. Feasibility of electric property tomography of pelvic tumors at 3T. Magn Reson Med 2015, 73:1505-1513.
108. Ludemann L., Wust P., Gellermann J. Perfusion measurement using DCE-MRI: implications for hyperthermia. Int J Hyperthermia 2008, 24:91-96.
109. Raaymakers B.W., van Vulpen M., Lagendijk J.J., De Leeuw A.A., Crezee J., Battermann J.J. Determination and validation of the actual 3D temperature distribution during interstitial hyperthermia of prostate carcinoma. Phys Med Biol 2001, 46:3115-3131.
110. Verhaart R.F., Rijnen Z., Fortunati V., Verduijn G.M., Walsum T.V., Veenland J.F., et al. Temperature simulations in hyperthermia treatment planning of the head and neck region: rigorous optimization of tissue properties. Strahlenther Onkol 2014, 190:1117-1124.
111. Kampinga H.H., Dynlacht J.R., Dikomey E. Mechanism of radiosensitization by hyperthermia (> or = 43°C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia 2004, 20:131-139.
112. Krawczyk P.M., Eppink B., Essers J., Stap J., Rodermond H., Odijk H., et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-Ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA 2011, 108:9851-9856.
113. Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys 1980, 6:1507-1517.
114. Kok H.P., Crezee J., Franken N.A., Stalpers L.J., Barendsen G.W., Bel A. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions. Int J Radiat Oncol Biol Phys 2014, 88:739-745.
115. Chatterjee D.K., Diagaradjane P., Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv 2011, 2:1001-1014.
116. Staruch R.M., Hynynen K., Chopra R. Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours. Int J Hyperthermia 2015, 31:133-188.
117. Dicheva B.M., Koning G.A. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors. Expert Opin Drug Deliv 2014, 11:83-100.
118. Burke A.R., Singh R.N., Carroll D.L., Wood J.C., D'Agostino R.B., Ajayan P.M., et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 2012, 33:2961-2970.
119. Maier-Hauff K., Ulrich F., Nestler D., Niehoff H., Wust P., Thiesen B., et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 2011, 103:317-324.
120. Johannsen M., Gneveckow U., Thiesen B., Taymoorian K., Cho C.H., Waldöfner N., et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007, 52:1653-1661.
121. Levegrün S., Jackson A., Zelefsky M.J., Skwarchuk M.W., Venkatraman E.S., Schlegel W., et al. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys 2001, 51:1064-1080.